Factors associated with discontinuation of glucocorticoids after starting biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients.

MLA

Mariko Inoue, et al. “Factors Associated with Discontinuation of Glucocorticoids after Starting Biological Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis Patients.” Modern Rheumatology, vol. 30, no. 1, Jan. 2020, pp. 58–63. EBSCOhost, https://doi.org/10.1080/14397595.2018.1553264.

APA

Mariko Inoue, Hiroko Kanda, Shoko Tateishi, & Keishi Fujio. (2020). Factors associated with discontinuation of glucocorticoids after starting biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients. Modern Rheumatology, 30(1), 58–63. https://doi.org/10.1080/14397595.2018.1553264

Chicago

Mariko Inoue, Hiroko Kanda, Shoko Tateishi, and Keishi Fujio. 2020. “Factors Associated with Discontinuation of Glucocorticoids after Starting Biological Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis Patients.” Modern Rheumatology 30 (1): 58–63. doi:10.1080/14397595.2018.1553264.